4//SEC Filing
Cellular Biomedicine Group, Inc. 4
Accession 0001354488-16-006460
CIK 0001378624operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:28 PM ET
Size
8.2 KB
Accession
0001354488-16-006460
Insider Transaction Report
Form 4
Cao Wei (William)
DirectorPresident and COO
Transactions
- Exercise/Conversion
Common Stock
2016-03-02$5.40/sh+7,500$40,500→ 181,972 total - Sale
Common Stock
2016-03-02$17.55/sh−7,500$131,625→ 174,472 total - Exercise/Conversion
Non- Qualified Stock Option (right to buy) (2013 Plan)
2016-03-02+7,500→ 42,500 totalExercise: $5.40Exp: 2023-09-30→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- [F2]The option vests according to the following schedule: 1/36th per month following the vesting commencement date of September 30, 2013.
Documents
Issuer
Cellular Biomedicine Group, Inc.
CIK 0001378624
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001378624
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:28 PM ET
- Size
- 8.2 KB